Vaccine

Pfizer to offer nearly two dozen low-cost products to poor nations

The products, which are widely available in the US and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions

Serum Institute likely to launch cervical cancer vaccine in India in Nov

Country now depends on foreign companies and Serum's product is likely to bring down prices.

UK brings in 21-day isolation measures to contain monkeypox spread

Smallpox vaccines are around 85 per cent effective in preventing monkeypox infection, and several countries have said they have begun stockpiling them

India-developed 'variant-proof' Covid vaccine likely in 2-3 years: Industry

Domestically produced variant-proof jabs are part of a global project to develop vaccines for future epidemics

Biological E plans to ramp up non-vaccines business in next three years

The privately held company has a turnover of about Rs 1,000 crore, of which close to 70-80 per cent come from the vaccines business now

With mRNA vaccine, India will have flexibility against Covid-19: Scientist

The Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) recently announced the development of the country's first potential mRNA vaccine candidate to fight against SARS-CoV-2

SII, Symbiosis to set up research centre for vaccine development

Serum Institute of India on Friday said it has signed an agreement with the Symbiosis International University earlier this month to set up a research centre for vaccines and biologicals. The R&D (Research & Development) centre will lead the development of new vaccines, technologies, products and innovations in immunisation practices that provide equitable access to life-saving interventions, especially across Low- and Middle-Income Countries (LMICs). The entity will work towards improving health equity against future pandemics and infectious diseases. It will also ensure cross-programme coordination and collaboration, as the facility will be an ecosystem that would also have R&D centres for stem cells, nanotechnology, medical image analysis, applied artificial intelligence and waste resource management, among others. "The research centre will be instrumental in advancing indigenous capabilities for end-to-end development of any futuristic technology and projects in the ...

Govt may not allow mixing of Covid-19 vaccines for booster shots

On May 4, Biological E submitted an application seeking emergency use authorisation for its Covid vaccine Corbevax as a booster dose in adults fully vaccinated with Covishield or Covaxin

What is Corbevax, the Covid-vaccine for your 5-year-old?

The DCGI has recently approved the emergency use of Covid-19 vaccine Corbevax for children aged five to 12. Find out more about the new vaccine and how it can boost the immune response

NTAGI meet this week to review vaccine data for 5-12 age group

A senior government official had told Business Standard last week that so far there was no scientific evidence to expand the vaccination programme to young children

SII's Covovax vaccine now available for 12-17 age group at private centres

A dose of Covovax will cost Rs 900 plus GST, in addition to hospital service charge of Rs 150, official sources told PTI

Covid booster shots won't be mandatory for all, says K Srinath Reddy

As cases of Covid-19 are rising in India, Business Standard's Bhaswar Kumar spoke to K Srinath Reddy, president of Public Health Foundation of India, about how the fourth wave is likely to play out

India faces global challenges from position of strength, says RBI article

The article on 'State of the Economy', published in the April 2022 RBI Bulletin, said India enters Samvat 2079 having crested the third wave of the pandemic

Kejriwal govt should provide free booster dose: Delhi Congress president

He said that the lockdown and closure of schools will not be the solution to deal with the pandemic

Covid-19: Delhi govt says free precaution doses at its hospitals soon

The move comes as the national capital witnesses an uptick in coronavirus cases and a rise in positivity rate

SII, Bharat Biotech cut Covid vaccine prices for pvt hospitals to Rs 225

SII and Bharat Biotech have been major suppliers of Covid-19 vaccines to the government so far

Cadila Pharma launches world's first novel 3-dose vaccine against rabies

The three-dose vaccine, named as 'ThRabis', is a recombinant nano-particle based G protein vaccine which is prepared using Virus-like Particle technology

Govt okays booster Covid shot for all adults at private centres from Apr 10

Around 22.8 mn precaution or booster dose have been administered to healthcare and frontline workers along with senior citizens after the population segments opened up in the first week of January.

CoWIN now allows submitting request to rectify Covid vaccination date

The portal already has a feature that allows one to rectify inadvertent errors in name, year of birth and gender on vaccination certificates

Don't slack off

Vaccination programme cannot lose govt attention